REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,124,000 | -20.6% | 14,000 | -6.7% | 1.40% | -8.4% |
| Q2 2019 | $1,415,000 | -33.8% | 15,000 | -40.0% | 1.53% | -27.6% |
| Q1 2019 | $2,137,000 | +52.3% | 25,000 | 0.0% | 2.11% | +20.2% |
| Q4 2018 | $1,403,000 | -28.2% | 25,000 | +4.6% | 1.76% | -15.2% |
| Q3 2018 | $1,954,000 | +39.7% | 23,900 | -40.2% | 2.07% | +46.8% |
| Q2 2018 | $1,399,000 | +13.6% | 40,000 | -33.3% | 1.41% | -4.5% |
| Q1 2018 | $1,231,000 | +8.6% | 60,000 | +50.0% | 1.48% | +3.8% |
| Q4 2017 | $1,133,000 | +21.4% | 40,000 | +33.3% | 1.42% | +45.7% |
| Q3 2017 | $933,000 | – | 30,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |